On 2024-02-13, VistaGen Therapeutics, Inc. (VTGN) announced earnings per share of $-0.22 for the fiscal quarter ending 2023-12-31, beating the average analyst estimate of $-0.31.
The next expected annoucement date for quarterly earnings is 2024-06-26, with an average estimated earnings per share of $-0.34 for the fiscal quarter ending 2024-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-02-13 | 2023-12-31 | $-0.31 | $-0.22 |
| 2023-11-09 | 2023-09-30 | -- | $-0.66 |
| 2023-08-10 | 2023-06-30 | -- | $-0.94 |
| 2023-02-07 | 2022-12-31 | $-1.80 | $-1.50 |
| 2022-11-10 | 2022-09-30 | $-2.40 | $-2.40 |
| 2022-08-11 | 2022-06-30 | $-2.70 | $-3.00 |
| 2022-06-23 | 2022-03-31 | $-1.80 | $-2.40 |
| 2022-02-10 | 2021-12-31 | $-2.40 | $-1.50 |
| 2021-11-10 | 2021-09-30 | $-1.50 | $-2.10 |
| 2021-08-12 | 2021-06-30 | $-1.50 | $-1.20 |
| 2021-06-29 | 2021-03-31 | $-1.50 | $-6.01 |
| 2021-02-11 | 2020-12-31 | $-1.50 | $-2.10 |
| 2020-11-12 | 2020-09-30 | $0.60 | $-1.50 |
| 2020-08-13 | 2020-06-30 | $-3.00 | $-2.10 |
| 2020-06-29 | 2020-03-31 | $-3.00 | $-3.90 |
| 2020-02-13 | 2019-12-31 | $-2.10 | $-4.50 |
| 2019-11-07 | 2019-09-30 | $-4.50 | $-3.90 |
| 2019-08-16 | 2019-06-30 | -- | $-4.50 |
| 2019-06-25 | 2019-03-31 | -- | $-4.50 |
| 2019-02-12 | 2018-12-31 | $-9.01 | $-7.21 |
| 2018-10-29 | 2018-09-30 | $-5.71 | $-9.01 |
| 2018-08-14 | 2018-06-30 | -- | $-6.01 |
| 2018-06-26 | 2018-03-31 | $-8.41 | $-5.71 |
| 2018-02-12 | 2017-12-31 | -- | $-7.21 |
| 2017-11-09 | 2017-09-30 | -- | $-15.92 |
| 2017-08-14 | 2017-06-30 | -- | $-8.41 |
| 2017-06-29 | 2017-03-31 | -- | $-9.61 |
| 2017-02-13 | 2016-12-31 | -- | $-10.21 |
| 2016-11-14 | 2016-09-30 | -- | $-12.61 |
| 2016-08-12 | 2016-06-30 | -- | $-15.32 |